<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03157375</url>
  </required_header>
  <id_info>
    <org_study_id>EK 1437/2014</org_study_id>
    <nct_id>NCT03157375</nct_id>
  </id_info>
  <brief_title>Rotation of an Intraocular Lens - HOYA Vivinex iSert P261</brief_title>
  <acronym>Rot P261</acronym>
  <official_title>Rotation of an Intraocular Lens - HOYA Vivinex iSert P261</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <brief_summary>
    <textblock>
      Age-related cataract is the main cause of impaired vision in the elderly population&#xD;
      worldwide. In the UK, more than half of people who are over 65 years old have some cataract&#xD;
      development in one or both eyes. The only treatment that can restore functional visual&#xD;
      ability is cataract surgery where the opacified crystalline lens is removed by&#xD;
      phacoemulsification and an artificial intraocular lens is implanted. It is estimated that&#xD;
      around 10 million cataract operations are performed around the world each year. Cataract&#xD;
      operations are generally very successful, with a low risk of serious complications.&#xD;
&#xD;
      During the past two decades, cataract surgery underwent tremendous change and modernisation&#xD;
      resulting in today's small incision phacoemulsification surgery and a safe technique with a&#xD;
      short rehabilitation time for the patient. Traditional spherical monofocal intraocular lenses&#xD;
      (IOLs) restore best-corrected vision and may lessen the need for spectacles. These IOLs&#xD;
      correct only the spherical portion of the total refractive error and do not correct corneal&#xD;
      astigmatism. Astigmatism is a visually disabling refractive error affecting the general&#xD;
      population, especially those with cataract. At least 15% to 20% of cataract patients have 1.5&#xD;
      diopters (D) or more of corneal or refractive astigmatism. With increased patient&#xD;
      expectations, the trend is not only to remove the cataract but also to address the problem of&#xD;
      pre-existing astigmatism at the time of surgery.&#xD;
&#xD;
      Surgical-induced astigmatism can be reduced by smaller incisions, i.e. microincision cataract&#xD;
      surgery (MICS), which by definition is surgery performed through incisions smaller than 2.0&#xD;
      mm, reducing the need for suturing. This results in better corneal optical quality, thus&#xD;
      improving visual outcomes. There are also other surgical options to correct preexisting&#xD;
      astigmatism during cataract surgery like: selectively positioning of the phacoemulsification&#xD;
      incision; astigmatic keratotomy with corneal or limbal relaxing incisions; excimer laser&#xD;
      refractive procedures such as photorefractive keratectomy, laser in situ keratomileusis, and&#xD;
      laser-assisted subepithelial keratectomy; or implanting pseudophakic toric posterior chamber&#xD;
      intraocular lenses (IOLs).&#xD;
&#xD;
      Toric IOLs have been shown to result in good visual and refractive outcomes. Combined with&#xD;
      MICS, these IOLs can allow effective correction of cylindrical errors intraoperatively,&#xD;
      improving visual quality and thus leading to spectacle independence. Plate haptic and loop&#xD;
      haptic toric IOLs have been considered for about a decade but have been associated with&#xD;
      postoperative rotational instability. Rotation of a toric lens from its intended orientation&#xD;
      degrades its corrective power, with approximately 3.3% loss of cylindrical power for every&#xD;
      degree off axis. A misorientation of approximately 30° negates the effectiveness of&#xD;
      astigmatic correction, and a misorientation of more than 30° may induce additional&#xD;
      astigmatism. Although some patients are asymptomatic despite induced astigmatism, others&#xD;
      experience symptoms such as blurred or distorted vision, headache, fatigue, eyestrain,&#xD;
      squinting, or eye discomfort. Thus, IOL orientation stability is an essential goal in toric&#xD;
      IOL design.&#xD;
&#xD;
      RATIONALE&#xD;
&#xD;
      The purpose of this study is to assess the axial IOL rotation and optical quality&#xD;
      (refraction, visual acuity, contrast sensitivity, decentration and tilt) and capsular bag&#xD;
      reaction after micro-incision surgery with an IOL implantation in cataract patients - HOYA&#xD;
      Vivinex iSert® model P261.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 6, 2014</start_date>
  <completion_date type="Actual">October 2, 2015</completion_date>
  <primary_completion_date type="Actual">October 2, 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of axial intraocular lens position</measure>
    <time_frame>7 months</time_frame>
    <description>Change in axial intraocular lens position from end of surgery (baseline axis) to 4-7 months (end of study visit)</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Intraocular Lens</condition>
  <arm_group>
    <arm_group_label>0°</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Implantation of the intraocular lens Vivinex p261 on axis 0°</description>
  </arm_group>
  <arm_group>
    <arm_group_label>45°</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Implantation of the intraocular lens Vivinex p261 on axis 45°</description>
  </arm_group>
  <arm_group>
    <arm_group_label>90°</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Implantation of the intraocular lens Vivinex p261 on axis 90°</description>
  </arm_group>
  <arm_group>
    <arm_group_label>135°</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Implantation of the intraocular lens Vivinex p261 on axis 135°</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intraocular Lens Implantation</intervention_name>
    <arm_group_label>0°</arm_group_label>
    <arm_group_label>135°</arm_group_label>
    <arm_group_label>45°</arm_group_label>
    <arm_group_label>90°</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Uni- or bilateral age-related cataract necessitating phacoemulsification extraction&#xD;
             and posterior IOL implantation&#xD;
&#xD;
          -  Need for spherical IOL correction between 15.00 and 25.00 D&#xD;
&#xD;
          -  Pupil dilation of ≥ 6.5 mm&#xD;
&#xD;
          -  Age 50 and older&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Corneal abnormality&#xD;
&#xD;
          -  Pseudoexfoliation&#xD;
&#xD;
          -  Preceding ocular surgery or trauma&#xD;
&#xD;
          -  Uncontrolled glaucoma&#xD;
&#xD;
          -  Proliferative diabetic retinopathy&#xD;
&#xD;
          -  Iris neovascularization&#xD;
&#xD;
          -  History of uveitis/iritis&#xD;
&#xD;
          -  Microphthalmus&#xD;
&#xD;
          -  Recurrent intraocular inflammation of unknown etiology&#xD;
&#xD;
          -  Blind fellow eye&#xD;
&#xD;
          -  Uncontrolled systemic or ocular disease&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University Vienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <study_first_submitted>May 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2017</study_first_posted>
  <last_update_submitted>May 15, 2017</last_update_submitted>
  <last_update_submitted_qc>May 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Rupert Menapace</investigator_full_name>
    <investigator_title>Prof.Dr. Rupert Menapace</investigator_title>
  </responsible_party>
  <keyword>IOL, IOL Rotation, Axial Rotation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

